Literature DB >> 501348

The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution.

Y Dalmaz, L Peyrin, J C Mamelle, D Tuil, R Gilly, J F Cier.   

Abstract

In this report we have tried to determine whether or not catecholamines are involved in the progressive muscular dystrophy. Catecholamines and their metabolites were studied in urines of children with Duchenne disease or other forms of myopathy (limb-girdle and facio-scapulo humeral myopathies). Catecholamine deaminated metabolites were normal in either form of myopathy; in contrast, Duchenne patients, contrarily to other children, eliminated excessive amounts of most amines (catecholamines and methoxylated amines) in relation to age and degree of disease evolution. Our results indicate that catecholamines are not the primary factors involved in the pathogenesis of Duchenne myopathy, but are rather secondary to some disease effects. It is suggested that the high excretion of catecholamines and their methoxylated amine metabolites observed in severely affected Duchenne boys might be related to thermoregulatory process or/and to alterations in some enzymatic systems.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 501348     DOI: 10.1007/bf01243426

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  54 in total

Review 1.  The effects of psychopharmacological agents on central nervous system amine metabolism in man.

Authors:  J W Maas
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  Abnormalities in membrane microviscosity and ion transport in genetic muscular dystrophy.

Authors:  R I Sha'afi; S B Rodan; R L Hintz; S M Fernandez; G A Rodan
Journal:  Nature       Date:  1975-04-10       Impact factor: 49.962

3.  The metabolism of adrenaline.

Authors:  Z M BACQ
Journal:  J Pharmacol Exp Ther       Date:  1949-04       Impact factor: 4.030

4.  Specific ion-exchange chromatography and fluorimetric assay for urinary 3-O-methyldopamine.

Authors:  Y Dalmaz; L Peyrin
Journal:  J Chromatogr       Date:  1976-01-21

5.  Adenyl cyclase in normal and pathologic human muscle.

Authors:  S Mawatari; A Takagi; L P Rowland
Journal:  Arch Neurol       Date:  1974-01

6.  Pargyline-induced myopathy with histochemical characteristics of Duchenne muscular dystrophy.

Authors:  M K Yu; T L Wright; W D Dettbarn; W H Olson
Journal:  Neurology       Date:  1974-03       Impact factor: 9.910

7.  Automated specific fluorimetric methods for epinephrine and norepinephrine assay in a single biological extract.

Authors:  L Peyrin; J M Cottet-Emard
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

8.  Urinary excretion of adrenaline metabolites in man during intervals of 2 minutes, 5 minutes, and 10 minutes after intravenous injection of adrenaline.

Authors:  M Goodall; H Alton
Journal:  Biochem Pharmacol       Date:  1965-11       Impact factor: 5.858

9.  Sequence of cardiac changes in Duchenne muscular dystrophy.

Authors:  S B Heymsfield; T McNish; J V Perkins; J M Felner
Journal:  Am Heart J       Date:  1978-03       Impact factor: 4.749

10.  Biochemical abnormalities of erythrocyte membranes in Duchenne dystrophy. Adenosine triphosphatase and adenyl cyclase.

Authors:  S Mawatari; M Schonberg; M Olarte
Journal:  Arch Neurol       Date:  1976-07
View more
  5 in total

1.  Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy.

Authors:  Tamara O Thomas; Thomas M Morgan; William B Burnette; Larry W Markham
Journal:  Pediatr Cardiol       Date:  2012-03-21       Impact factor: 1.655

Review 2.  Heart Rate Variability and Cardiopulmonary Dysfunction in Patients with Duchenne Muscular Dystrophy: A Systematic Review.

Authors:  Talita Dias da Silva; Thais Massetti; Tânia Brusque Crocetta; Carlos Bandeira de Mello Monteiro; Alex Carll; Luiz Carlos Marques Vanderlei; Carlie Arbaugh; Fernando Rocha Oliveira; Luiz Carlos de Abreu; Celso Ferreira Filho; John Godleski; Celso Ferreira
Journal:  Pediatr Cardiol       Date:  2018-04-25       Impact factor: 1.655

Review 3.  Oxidative stress in muscular dystrophy: from generic evidence to specific sources and targets.

Authors:  Marcella Canton; Sara Menazza; Fabio Di Lisa
Journal:  J Muscle Res Cell Motil       Date:  2014-03-12       Impact factor: 2.698

4.  Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies.

Authors:  E Sorato; S Menazza; A Zulian; P Sabatelli; F Gualandi; L Merlini; P Bonaldo; M Canton; P Bernardi; F Di Lisa
Journal:  Free Radic Biol Med       Date:  2014-07-10       Impact factor: 7.376

Review 5.  The multifaceted view of heart problem in Duchenne muscular dystrophy.

Authors:  Urszula Florczyk-Soluch; Katarzyna Polak; Józef Dulak
Journal:  Cell Mol Life Sci       Date:  2021-06-06       Impact factor: 9.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.